Cargando…
Increased expression of MMP17 predicts poor clinical outcomes in epithelial ovarian cancer patients
Ovarian cancer has the highest fatality rate among female reproductive system cancers, which is due to lack of biomarker for diagnosis and prognosis. We aimed to evaluate the role of matrix metalloproteinase 17 (MMP17) in ovarian cancer tumorigenesis and prognosis. Based on the epithelial ovarian ca...
Autores principales: | Xiao, Chao, Wang, Yao, Cheng, Qijun, Fan, Yuchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410588/ https://www.ncbi.nlm.nih.gov/pubmed/36042626 http://dx.doi.org/10.1097/MD.0000000000030279 |
Ejemplares similares
-
ADAM17 Mediates MMP9 Expression in Lung Epithelial Cells
por: Li, Ya-qing, et al.
Publicado: (2013) -
Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma
por: Liu, Zhen, et al.
Publicado: (2010) -
Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors
por: Morales-Vásquez, Flavia, et al.
Publicado: (2020) -
High MMP-26 expression in glioma is correlated with poor clinical outcome of patients
por: Guo, Jian-Gui, et al.
Publicado: (2018) -
Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients
por: Hosono, S, et al.
Publicado: (2007)